HCIL Stock Overview
Engages in the food trading and biotechnology businesses in China, the United States, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Hongchang International Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.13 |
52 Week High | US$0.60 |
52 Week Low | US$0.13 |
Beta | 0 |
11 Month Change | -45.35% |
3 Month Change | n/a |
1 Year Change | -63.57% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -83.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
HCIL | US Consumer Retailing | US Market | |
---|---|---|---|
7D | -47.3% | 5.1% | 2.2% |
1Y | -63.6% | 50.6% | 31.6% |
Return vs Industry: HCIL underperformed the US Consumer Retailing industry which returned 50.6% over the past year.
Return vs Market: HCIL underperformed the US Market which returned 31.7% over the past year.
Price Volatility
HCIL volatility | |
---|---|
HCIL Average Weekly Movement | n/a |
Consumer Retailing Industry Average Movement | 6.9% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: HCIL's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine HCIL's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Zengqiang Lin | n/a |
Hongchang International Co., Ltd engages in the food trading and biotechnology businesses in China, the United States, and internationally. It also offers technical and consultation services. The company is based in Fuzhou, China.
Hongchang International Co., Ltd Fundamentals Summary
HCIL fundamental statistics | |
---|---|
Market cap | US$66.15m |
Earnings (TTM) | -US$208.79k |
Revenue (TTM) | US$5.42m |
12.2x
P/S Ratio-316.8x
P/E RatioIs HCIL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HCIL income statement (TTM) | |
---|---|
Revenue | US$5.42m |
Cost of Revenue | US$5.17m |
Gross Profit | US$244.16k |
Other Expenses | US$452.95k |
Earnings | -US$208.79k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0004 |
Gross Margin | 4.51% |
Net Profit Margin | -3.85% |
Debt/Equity Ratio | 15.9% |
How did HCIL perform over the long term?
See historical performance and comparison